KRT5 (Keratin, type II cytoskeletal 5) variants and mutations
KRT5 (also known as Keratin, type II cytoskeletal 5) is a human protein-coding gene encoding a keratin, type II cytoskeletal 5 protein. It pairs with keratin 14 to form the primary intermediate-filament scaffold of basal epidermal keratinocytes. Dominant pathogenic variants are a major cause of epidermolysis bullosa simplex, while other alleles can cause pigmentary disorders such as Dowling-Degos disease. This analysis covers 1,140 KRT5 variants and mutations. Of these, 79% have computational variant effect predictions. Disease context includes epidermolysis bullosa simplex 2C, localized, epidermolysis bullosa simplex 2A, generalized severe, and epidermolysis bullosa simplex 2B, generalized intermediate. Example KRT5 variants include M1T, M1V, and R3C.
Variant analysis overview
- Gene: KRT5
- Protein: Keratin, type II cytoskeletal 5
- UniProt accession: P13647
- Organism: Homo sapiens
- Variants analyzed: 1140
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 870 unspecified-consequence records; 1 stop retained variant; 125 missense variants; 112 synonymous variants; 7 in-frame deletions; 12 frameshift variants; 2 in-frame insertions; 9 stop-gained variants; 3 splice-region variants; 2 stop lost
- Prediction scores: 901 variants have prediction scores (79% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: epidermolysis bullosa simplex 2C, localized, epidermolysis bullosa simplex 2A, generalized severe, epidermolysis bullosa simplex 2B, generalized intermediate, Dowling-Degos disease 1, Epidermolysis bullosa simplex with mottled pigmentation, Epidermolysis bullosa simplex, Dowling-Meara type, Localized epidermolysis bullosa simplex, epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal, epidermolysis bullosa simplex, Dowling-Degos disease, epidermolysis bullosa simplex 2F, with mottled pigmentation, epidermolysis bullosa simplex 1A, generalized severe.
Protein structure and variant hotspots
- Protein features: 1 domains; 13 post-translational modification sites.
- Structural context: 548 variants have structural context.
- PTM context: 17 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT5 variants
Examples include M1T, M1V, R3C, R3H, Q4*, Q4P, S5*, S5L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1T (p.Met1Thr), rs267607444, ClinGen CA216703, ClinVar RCV000056584, MetaLR 0.25, MetaSVM -0.51, not provided
- M1V (p.Met1Val), rs1064793977, ClinGen CA16619574, ClinVar RCV000484793, MetaLR 0.28, MetaSVM -0.62, Pathogenic, not provided
- R3C (p.Arg3Cys), rs200156424, NCI-TCGA Cosmic COSV5286, ExAC rs200156424, TOPMed rs200156424, REVEL 0.49, CADD 32.00, Variant assessed as somatic; moderate impact.
- R3H (p.Arg3His), ExAC rs770091254, TOPMed rs770091254, gnomAD rs770091254, REVEL 0.35, CADD 26.90
- Q4* (p.Gln4Ter), rs267607455, ClinGen CA216643, ClinVar RCV000056543, Ensembl rs267607455, Pathogenic
- Q4P (p.Gln4Pro), TOPMed rs1473238308, gnomAD rs1473238308, REVEL 0.35, CADD 24.10
- S5* (p.Ser5Ter), rs58751565, ClinGen CA124171, ClinVar RCV000015753, ClinVar RCV000056572, CADD 40.00, Pathogenic
- S5L (p.Ser5Leu), ExAC rs58751565, TOPMed rs58751565, gnomAD rs58751565, REVEL 0.24, CADD 24.90, Pathogenic
- S5P (p.Ser5Pro), gnomAD rs1267266121, REVEL 0.14, CADD 24.10
- S6R (p.Ser6Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S6T (p.Ser6Thr), Ensembl rs967437376
- V7A (p.Val7Ala), rs121912474, ClinGen CA257295, ClinVar RCV001731296, TOPMed rs121912474, AlphaMissense 0.37, MetaLR 0.16, Pathogenic, Epidermolysis bullosa simplex 2B, generalized intermediate
- V7E (p.Val7Glu), TOPMed rs121912474, Pathogenic
- S8F (p.Ser8Phe), rs913174272, NCI-TCGA Cosmic COSV9935, gnomAD rs913174272, REVEL 0.12, CADD 23.80, Variant assessed as somatic; moderate impact.
- F9L (p.Phe9Leu), ESP rs367853808, ExAC rs367853808, REVEL 0.19, CADD 19.20
- R10G (p.Arg10Gly), 1000Genomes rs148526538, ESP rs148526538, ExAC rs148526538, TOPMed rs148526538, REVEL 0.21, CADD 22.40, Uncertain significance
- R10Q (p.Arg10Gln), rs753298083, NCI-TCGA Cosmic COSV5285, ExAC rs753298083, TOPMed rs753298083, REVEL 0.06, CADD 18.30, Variant assessed as somatic; moderate impact.
- R10W (p.Arg10Trp), 1000Genomes rs148526538, ESP rs148526538, ExAC rs148526538, TOPMed rs148526538, REVEL 0.17, CADD 24.20, Uncertain significance, Inborn genetic diseases
- S11G (p.Ser11Gly), ExAC rs755664811, gnomAD rs755664811, REVEL 0.12, CADD 23.60
- S11N (p.Ser11Asn), ExAC rs750089477, gnomAD rs750089477
- G12R (p.Gly12Arg), ExAC rs751876144, TOPMed rs751876144, gnomAD rs751876144, REVEL 0.10, CADD 19.30, Uncertain significance, not provided
- G12W (p.Gly12Trp), ExAC rs751876144, TOPMed rs751876144, gnomAD rs751876144, REVEL 0.33, CADD 24.20
- G13D (p.Gly13Asp), rs1367644026, NCI-TCGA Cosmic COSV9935, TOPMed rs1367644026, gnomAD rs1367644026, REVEL 0.33, CADD 23.80, Variant assessed as somatic; moderate impact.
- G13V (p.Gly13Val), TOPMed rs1367644026, gnomAD rs1367644026, REVEL 0.24, CADD 22.30
- R15C (p.Arg15Cys), rs374322915, ClinGen CA6582948, ClinVar RCV002936544, 1000Genomes rs374322915, REVEL 0.38, AlphaMissense 0.16, Uncertain significance, Inborn genetic diseases
- R15G (p.Arg15Gly), rs374322915, ClinGen CA384931365, ClinVar RCV002273696, 1000Genomes rs374322915, AlphaMissense 0.16, MetaLR 0.18, Uncertain significance, not provided
- R15H (p.Arg15His), 1000Genomes rs372305341, ESP rs372305341, ExAC rs372305341, TOPMed rs372305341
- R15L (p.Arg15Leu), 1000Genomes rs372305341, ESP rs372305341, ExAC rs372305341, TOPMed rs372305341
- R15P (p.Arg15Pro), 1000Genomes rs372305341, ESP rs372305341, ExAC rs372305341, TOPMed rs372305341
- F17S (p.Phe17Ser), Ensembl rs1592195681
- T19A (p.Thr19Ala), ExAC rs769963375, gnomAD rs769963375, REVEL 0.03, CADD 3.31
- T19I (p.Thr19Ile), gnomAD rs1458034065, REVEL 0.09, CADD 23.10, Uncertain significance, Inborn genetic diseases
- T19P (p.Thr19Pro), ExAC rs769963375, gnomAD rs769963375
- A20T (p.Ala20Thr), rs776895650, ClinGen CA6582944, ClinVar RCV003207322, ClinVar RCV004753666, REVEL 0.22, CADD 20.80, Uncertain significance, Inborn genetic diseases; not provided
- A20V (p.Ala20Val), Ensembl rs1565594276
- S21F (p.Ser21Phe), ESP rs368584130, ExAC rs368584130, TOPMed rs368584130, gnomAD rs368584130, REVEL 0.44, CADD 24.90
- S21Y (p.Ser21Tyr), ESP rs368584130, ExAC rs368584130, TOPMed rs368584130, gnomAD rs368584130, REVEL 0.58, CADD 27.30
- A22D (p.Ala22Asp), ESP rs374462183, ExAC rs374462183, TOPMed rs374462183, gnomAD rs374462183
- A22G (p.Ala22Gly), ESP rs374462183, ExAC rs374462183, TOPMed rs374462183, gnomAD rs374462183, REVEL 0.44, CADD 28.20
- I23L (p.Ile23Leu), gnomAD rs1463762295
- I23T (p.Ile23Thr), Ensembl rs1809920681, REVEL 0.21, CADD 20.60
- I23V (p.Ile23Val), rs1463762295, gnomAD rs1463762295, REVEL 0.10, CADD 8.27, Variant assessed as somatic; moderate impact.
- T24N (p.Thr24Asn), rs768490644, ExAC rs768490644, TOPMed rs768490644, gnomAD rs768490644, REVEL 0.14, CADD 23.70, Uncertain significance
- T24P (p.Thr24Pro), Ensembl rs1592195666
- T24S (p.Thr24Ser), rs768490644, ClinGen CA6582940, ClinVar RCV004414404, ExAC rs768490644, REVEL 0.10, CADD 23.60, Uncertain significance, Inborn genetic diseases
- P25L (p.Pro25Leu), rs57499817, ClinGen CA216792, ClinVar RCV000015754, ClinVar RCV000056643, REVEL 0.41, CADD 23.20, Pathogenic, Inborn genetic diseases; not provided; Epidermolysis bullosa simplex
- P25S (p.Pro25Ser), NCI-TCGA Cosmic COSV5286, TOPMed rs1938694555, Variant assessed as somatic; moderate impact., in EBS2F
- S26F (p.Ser26Phe), NCI-TCGA Cosmic COSV5286, REVEL 0.34, CADD 25.40, Variant assessed as somatic; moderate impact.
- V27I (p.Val27Ile), gnomAD rs1235374200
- S28F (p.Ser28Phe), rs1312675397, TOPMed rs1312675397, gnomAD rs1312675397, REVEL 0.20, CADD 23.40, Variant assessed as somatic; moderate impact.
- R29C (p.Arg29Cys), TOPMed rs1274640779, gnomAD rs1274640779, REVEL 0.38, CADD 25.90
- R29H (p.Arg29His), rs543574061, ClinGen CA6582937, NCI-TCGA Cosmic COSV5286, ClinVar RCV002127523, REVEL 0.30, CADD 23.10, Conflicting interpretations, not provided
- R29L (p.Arg29Leu), 1000Genomes rs543574061, ExAC rs543574061, TOPMed rs543574061, gnomAD rs543574061, REVEL 0.32, CADD 23.10, Uncertain significance
- T30P (p.Thr30Pro), Ensembl rs1592195638
- S31P (p.Ser31Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- T33N (p.Thr33Asn), gnomAD rs1366922155, REVEL 0.07, CADD 17.60
- T33P (p.Thr33Pro), Ensembl rs1592195626
- S34F (p.Ser34Phe), Ensembl rs11549952
- V35M (p.Val35Met), rs374017172, 1000Genomes rs374017172, ESP rs374017172, ExAC rs374017172, REVEL 0.18, CADD 22.00, Variant assessed as somatic; moderate impact.
- V35P (p.Val35Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S36Y (p.Ser36Tyr), gnomAD rs1938693726, REVEL 0.40, CADD 24.40
- R37L (p.Arg37Leu), 1000Genomes rs61747181, ESP rs61747181, ExAC rs61747181, TOPMed rs61747181, REVEL 0.29, CADD 19.70, Benign
- R37P (p.Arg37Pro), 1000Genomes rs61747181, ESP rs61747181, ExAC rs61747181, TOPMed rs61747181, Benign
- R37Q (p.Arg37Gln), rs61747181, ClinGen CA6582927, ClinVar RCV000307467, ClinVar RCV000897081, REVEL 0.06, CADD 21.20, Benign/Likely benign, Dowling-Degos disease 1; Epidermolysis bullosa simplex with migratory circinate
- R37W (p.Arg37Trp), rs370714132, ClinGen CA6582929, ClinVar RCV002508484, ESP rs370714132, REVEL 0.28, CADD 23.10, Uncertain significance, not provided
- S38A (p.Ser38Ala), 1000Genomes rs541279700, ExAC rs541279700, TOPMed rs541279700, gnomAD rs541279700, REVEL 0.07, CADD 19.20, Likely benign, not provided
- S38F (p.Ser38Phe), gnomAD rs1168120051, REVEL 0.35, CADD 23.70
- G39R (p.Gly39Arg), rs146136560, ClinGen CA6582924, ClinVar RCV000268669, ClinVar RCV002522235, CADD 2.58, Conflicting interpretations, Inborn genetic diseases; Epidermolysis bullosa simplex
- G39V (p.Gly39Val), ExAC rs773464963, TOPMed rs773464963, gnomAD rs773464963, REVEL 0.52, CADD 16.90
- G39W (p.Gly39Trp), ESP rs146136560, ExAC rs146136560, TOPMed rs146136560, gnomAD rs146136560, Likely benign
- G40D (p.Gly40Asp), ExAC rs749140215, TOPMed rs749140215, gnomAD rs749140215, REVEL 0.51, CADD 25.20
- G40V (p.Gly40Val), ExAC rs749140215, TOPMed rs749140215, gnomAD rs749140215, REVEL 0.41, CADD 23.40
- G41D (p.Gly41Asp), gnomAD rs1170652770, REVEL 0.44, CADD 22.10
- G41S (p.Gly41Ser), ExAC rs775353075, TOPMed rs775353075, gnomAD rs775353075, REVEL 0.32, CADD 22.90
- G42S (p.Gly42Ser), rs201264698, ClinGen CA6582918, ClinVar RCV003000658, ClinVar RCV005099003, REVEL 0.30, CADD 16.50, Uncertain significance, Inborn genetic diseases; not provided
- G43S (p.Gly43Ser), Ensembl rs376866139
- G44V (p.Gly44Val), rs375759050, ClinGen CA6582917, ClinVar RCV004414398, ExAC rs375759050, REVEL 0.55, CADD 24.90, Uncertain significance, Inborn genetic diseases
- G45S (p.Gly45Ser), ExAC rs756838467, gnomAD rs756838467, REVEL 0.24, CADD 16.50
- F46I (p.Phe46Ile), rs777631293, ClinGen CA6582914, ClinVar RCV003717258, ClinVar RCV005655340, REVEL 0.06, CADD 13.30, Conflicting interpretations, Inborn genetic diseases; not provided
- F46L (p.Phe46Leu), ExAC rs777631293, TOPMed rs777631293, gnomAD rs777631293, Likely benign
- G47S (p.Gly47Ser), ESP rs144480716, ExAC rs144480716, TOPMed rs144480716, gnomAD rs144480716, REVEL 0.13, CADD 15.40
- R48G (p.Arg48Gly), 1000Genomes rs61747180, ESP rs61747180, ExAC rs61747180, TOPMed rs61747180, REVEL 0.32, CADD 19.00, Benign
- R48K (p.Arg48Lys), TOPMed rs1403548834, gnomAD rs1403548834, REVEL 0.18, CADD 21.10
- V49G (p.Val49Gly), ExAC rs760876234, gnomAD rs760876234, REVEL 0.15, CADD 20.20
- S50T (p.Ser50Thr), TOPMed rs199505033, gnomAD rs199505033, REVEL 0.27, CADD 20.20, Uncertain significance, Inborn genetic diseases
- A52E (p.Ala52Glu), ExAC rs773410009, TOPMed rs773410009, gnomAD rs773410009, REVEL 0.13, CADD 16.30
- A52G (p.Ala52Gly), ExAC rs773410009, TOPMed rs773410009, gnomAD rs773410009, REVEL 0.07, CADD 8.52
- A52S (p.Ala52Ser), Ensembl rs1938692265, REVEL 0.10, CADD 11.20
- A52V (p.Ala52Val), ExAC rs773410009, TOPMed rs773410009, gnomAD rs773410009, REVEL 0.13, CADD 13.60
- G53D (p.Gly53Asp), rs556992218, ClinGen CA6582903, ClinVar RCV002846137, 1000Genomes rs556992218, REVEL 0.38, CADD 21.80, Uncertain significance, Inborn genetic diseases
- G53V (p.Gly53Val), 1000Genomes rs556992218, ExAC rs556992218, TOPMed rs556992218, gnomAD rs556992218, Uncertain significance
- A54D (p.Ala54Asp), Ensembl rs1026026988
- A54T (p.Ala54Thr), rs1366927682, ClinGen CA384930682, ClinVar RCV002943754, TOPMed rs1366927682, REVEL 0.35, CADD 16.40, Uncertain significance, not provided
- G58C (p.Gly58Cys), TOPMed rs1938691631, REVEL 0.52, CADD 23.00
- G58D (p.Gly58Asp), Ensembl rs1938691568
- G59V (p.Gly59Val), rs769725141, ClinGen CA6582902, ClinVar RCV004414399, 1000Genomes rs769725141, REVEL 0.53, CADD 24.70, Uncertain significance, Inborn genetic diseases
- Y60N (p.Tyr60Asn), NCI-TCGA Cosmic COSV5286, Variant assessed as somatic; moderate impact.
- S62G (p.Ser62Gly), rs2498410129, ClinGen CA384930546, ClinVar RCV002713400, REVEL 0.09, CADD 23.10, Uncertain significance, Inborn genetic diseases
- S62R (p.Ser62Arg), ExAC rs745773711, gnomAD rs745773711, REVEL 0.27, CADD 21.90
- R63Q (p.Arg63Gln), ESP rs375273687, ExAC rs375273687, TOPMed rs375273687, gnomAD rs375273687, REVEL 0.26, CADD 22.90
- R63W (p.Arg63Trp), rs776667863, ClinGen CA6582900, NCI-TCGA Cosmic COSV9935, ClinVar RCV000975479, REVEL 0.51, CADD 24.40, Conflicting interpretations, not provided; Inborn genetic diseases
- L65F (p.Leu65Phe), NCI-TCGA Cosmic COSV9935, Variant assessed as somatic; moderate impact.
- L65I (p.Leu65Ile), NCI-TCGA Cosmic COSV9935, Variant assessed as somatic; moderate impact.
- N67S (p.Asn67Ser), TOPMed rs1007089956, REVEL 0.10, CADD 14.80, Uncertain significance, Inborn genetic diseases
- L68M (p.Leu68Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G69E (p.Gly69Glu), TOPMed rs1374537032
- G69R (p.Gly69Arg), rs1565594178, ClinGen CA384930391, ClinVar RCV003680930, TOPMed rs1565594178, AlphaMissense 0.85, MetaLR 0.66, Uncertain significance, not provided
- G70A (p.Gly70Ala), rs1565594174, NCI-TCGA Cosmic COSV5286, REVEL 0.32, CADD 20.50, Variant assessed as somatic; high impact.
- G70D (p.Gly70Asp), ExAC rs540081758, TOPMed rs540081758, gnomAD rs540081758, REVEL 0.41, CADD 23.10
- G70V (p.Gly70Val), ExAC rs540081758, TOPMed rs540081758, gnomAD rs540081758, REVEL 0.37, CADD 23.10
- S71L (p.Ser71Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- R73T (p.Arg73Thr), TOPMed rs1285526841, gnomAD rs1285526841, REVEL 0.18, CADD 21.30
- I74L (p.Ile74Leu), ExAC rs779166505, gnomAD rs779166505
- I74T (p.Ile74Thr), TOPMed rs1463063008, gnomAD rs1463063008, REVEL 0.20, CADD 21.40
- I74V (p.Ile74Val), ExAC rs779166505, gnomAD rs779166505, REVEL 0.09, CADD 17.30
- S75P (p.Ser75Pro), TOPMed rs1283483642, gnomAD rs1283483642, REVEL 0.34, CADD 22.80
- S75Y (p.Ser75Tyr), rs755413229, ClinGen CA6582892, ClinVar RCV001262257, ClinVar RCV002537630, REVEL 0.38, CADD 23.60, Uncertain significance, Inborn genetic diseases; Dowling-Degos disease 1
- I76S (p.Ile76Ser), gnomAD rs1288077456
- S77I (p.Ser77Ile), NCI-TCGA Cosmic COSV9935, REVEL 0.11, CADD 22.70, Variant assessed as somatic; high impact.
- T78S (p.Thr78Ser), ExAC rs754297557, gnomAD rs754297557, REVEL 0.12, CADD 7.19
- S79I (p.Ser79Ile), NCI-TCGA TCGA novel, REVEL 0.12, CADD 16.10, Variant assessed as somatic; moderate impact.
- S79R (p.Ser79Arg), rs1065115, ClinGen CA216699, ClinVar RCV000056582, UniProt VAR 028763, REVEL 0.19, CADD 9.48, not provided
- G81S (p.Gly81Ser), gnomAD rs1938689437, REVEL 0.05, CADD 14.20
- S82R (p.Ser82Arg), TOPMed rs1938689369, gnomAD rs1938689369, REVEL 0.03, CADD 5.91
- F83L (p.Phe83Leu), rs1372929067, ClinGen CA384930141, ClinVar RCV001115127, ClinVar RCV005652518, REVEL 0.06, CADD 19.60, Uncertain significance, Inborn genetic diseases; Epidermolysis bullosa simplex
- R84K (p.Arg84Lys), Ensembl rs868576880
- N85S (p.Asn85Ser), ExAC rs756129437, TOPMed rs756129437, gnomAD rs756129437, REVEL 0.03, CADD 10.50
- R86P (p.Arg86Pro), ExAC rs762047842, TOPMed rs762047842, gnomAD rs762047842, REVEL 0.11, CADD 15.80, Uncertain significance
- R86Q (p.Arg86Gln), rs762047842, ClinGen CA6582886, ClinVar RCV002683564, ExAC rs762047842, REVEL 0.07, CADD 15.60, Uncertain significance, Inborn genetic diseases
- R86W (p.Arg86Trp), rs373163099, ClinGen CA6582888, ClinVar RCV003086465, ClinVar RCV004073197, REVEL 0.09, CADD 22.40, Uncertain significance, Inborn genetic diseases; not provided
- F87S (p.Phe87Ser), ESP rs375333850, ExAC rs375333850, TOPMed rs375333850, gnomAD rs375333850, REVEL 0.03, CADD 14.60
- F87V (p.Phe87Val), rs61747188, ClinGen CA6582884, ClinVar RCV000348479, ClinVar RCV000957065, REVEL 0.03, CADD 16.60, Benign, not provided; Epidermolysis bullosa simplex
- G88C (p.Gly88Cys), ExAC rs770910564, TOPMed rs770910564, gnomAD rs770910564, REVEL 0.16, CADD 13.40
- G88S (p.Gly88Ser), ExAC rs770910564, TOPMed rs770910564, gnomAD rs770910564
- A89D (p.Ala89Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A89S (p.Ala89Ser), TOPMed rs1207950244, gnomAD rs1207950244, REVEL 0.06, CADD 6.59
- A89T (p.Ala89Thr), TOPMed rs1207950244, gnomAD rs1207950244, REVEL 0.05, CADD 12.40
- A89V (p.Ala89Val), gnomAD rs1252446552, REVEL 0.12, CADD 10.40
- G90S (p.Gly90Ser), Ensembl rs1262135056
- A91T (p.Ala91Thr), ESP rs142778320, ExAC rs142778320, TOPMed rs142778320, gnomAD rs142778320, REVEL 0.08, CADD 15.90
- G92R (p.Gly92Arg), TOPMed rs1428870322, gnomAD rs1428870322, REVEL 0.30, CADD 22.60
- G93S (p.Gly93Ser), rs1415918495, NCI-TCGA Cosmic COSV9935, gnomAD rs1415918495, Variant assessed as somatic; moderate impact.
- G94D (p.Gly94Asp), ExAC rs778696476, TOPMed rs778696476, gnomAD rs778696476, REVEL 0.40, CADD 21.60
- G94S (p.Gly94Ser), rs138806570, ClinGen CA6582877, ClinVar RCV000900885, ClinVar RCV004731057, REVEL 0.11, CADD 10.30, Benign/Likely benign, not provided
- Y95C (p.Tyr95Cys), gnomAD rs1267955312, REVEL 0.04, CADD 15.10, Uncertain significance, not provided
- G96D (p.Gly96Asp), rs768890570, ExAC rs768890570, TOPMed rs768890570, gnomAD rs768890570, REVEL 0.60, CADD 23.30, Variant assessed as somatic; moderate impact.
- G98* (p.Gly98Ter), Ensembl rs75907817
- G98E (p.Gly98Glu), 1000Genomes rs534913364, ExAC rs534913364, TOPMed rs534913364, gnomAD rs534913364, REVEL 0.52, CADD 24.50
- G98V (p.Gly98Val), 1000Genomes rs534913364, ExAC rs534913364, TOPMed rs534913364, gnomAD rs534913364, REVEL 0.48, CADD 24.80
- G100D (p.Gly100Asp), ExAC rs780359251, TOPMed rs780359251, gnomAD rs780359251, REVEL 0.34, CADD 21.70
- A101D (p.Ala101Asp), gnomAD rs1325571536
- A101T (p.Ala101Thr), rs372204272, ClinGen CA6582872, ClinVar RCV002571058, ClinVar RCV003164789, REVEL 0.07, CADD 17.60, Uncertain significance, Inborn genetic diseases; not provided
- A101V (p.Ala101Val), gnomAD rs1325571536
- G102A (p.Gly102Ala), Ensembl rs1592195463
- G102S (p.Gly102Ser), rs539432563, NCI-TCGA Cosmic COSV5286, ExAC rs539432563, TOPMed rs539432563, REVEL 0.43, CADD 16.40, Uncertain significance, not provided
- S103N (p.Ser103Asn), Ensembl rs1938686987
- G104E (p.Gly104Glu), ExAC rs757370875, gnomAD rs757370875, REVEL 0.25, CADD 24.70
- G104R (p.Gly104Arg), NCI-TCGA Cosmic COSV5285, REVEL 0.30, CADD 24.70, Variant assessed as somatic; moderate impact.
- F105L (p.Phe105Leu), TOPMed rs1938686826
- G106S (p.Gly106Ser), TOPMed rs1938686754
- F107L (p.Phe107Leu), NCI-TCGA Cosmic COSV9935, Variant assessed as somatic; moderate impact.
- F107Y (p.Phe107Tyr), gnomAD rs1237453275, REVEL 0.16, CADD 18.50
- G108C (p.Gly108Cys), NCI-TCGA TCGA novel, 1000Genomes rs146022149, ESP rs146022149, ExAC rs146022149, REVEL 0.47, CADD 23.30, Likely benign
- G108D (p.Gly108Asp), ExAC rs764430671, gnomAD rs764430671, REVEL 0.50, CADD 25.30
- G108R (p.Gly108Arg), 1000Genomes rs146022149, ESP rs146022149, ExAC rs146022149, TOPMed rs146022149, REVEL 0.54, CADD 24.90, Likely benign
- G108S (p.Gly108Ser), rs146022149, ClinGen CA6582868, ClinVar RCV001771524, ClinVar RCV003910997, REVEL 0.40, CADD 21.50, Conflicting interpretations, not provided
- G109C (p.Gly109Cys), ExAC rs753671394, TOPMed rs753671394, gnomAD rs753671394
- G109S (p.Gly109Ser), ExAC rs753671394, TOPMed rs753671394, gnomAD rs753671394, REVEL 0.17, CADD 17.70
- G109V (p.Gly109Val), ExAC rs766378801, TOPMed rs766378801, gnomAD rs766378801, REVEL 0.28, CADD 17.90, Uncertain significance, Inborn genetic diseases
- G110E (p.Gly110Glu), gnomAD rs1938686018, REVEL 0.44, CADD 25.50
- A111D (p.Ala111Asp), NCI-TCGA Cosmic COSV9935, Variant assessed as somatic; moderate impact.
- A111S (p.Ala111Ser), gnomAD rs1245745607, REVEL 0.15, CADD 14.50
- G112S (p.Gly112Ser), Ensembl rs1938685845
- G112V (p.Gly112Val), ExAC rs760710214, gnomAD rs760710214, REVEL 0.51, CADD 17.60
- G114S (p.Gly114Ser), TOPMed rs1938685729
- F115S (p.Phe115Ser), TOPMed rs1262403815, gnomAD rs1262403815, REVEL 0.07, CADD 19.90
- G116E (p.Gly116Glu), 1000Genomes rs549383569, ExAC rs549383569, gnomAD rs549383569, REVEL 0.50, CADD 23.60
- L117F (p.Leu117Phe), TOPMed rs1219197486, gnomAD rs1219197486, REVEL 0.14, CADD 13.00
- L117I (p.Leu117Ile), TOPMed rs1219197486, gnomAD rs1219197486, REVEL 0.12, CADD 13.60
- L117P (p.Leu117Pro), NCI-TCGA TCGA novel, REVEL 0.24, CADD 19.70, Variant assessed as somatic; moderate impact.
Public KRT5 analysis runs
- KRT5 analysis run — KRT5 (1,140 variants) — completed 2026-08-21